CAR_Public/040426.mbx             C L A S S   A C T I O N   R E P O R T E R

             Monday, April 26, 2004, Vol. 6, No. 81

                         Headlines

ALFRED TEO: SEC Files Securities Lawsuit Due To Insider Trading
ALIANT TELECOM: Discovery Commences in Canada Retirement Lawsuit
AMERICAN HONDA: Recalls 440T Civic, Insight Cars For Overheating
ARMOR HOLDINGS: Denies Allegations in FL Bullet-Proof Vest Suit
ASHLEY FURNITURE: Recalls Bunk Beds Due to Strangulation Hazard

CALIFORNIA BANKS: Consumers File Fraud Suit V. BofA, Wells Fargo
CIGNA HEALTHCARE: Physician Suit Settlement Appeals Dropped
DAIMLERCHRYSLER CORPORATION: Recalls Cars For Seat-Belt Defect
ELECTRO SCIENTIFIC: Reaches $9M Settlement For Securities Suits
ELI LILLY: Zyprexa Consumer Litigation Moved To New York Court

ENTRAN II HOSE: Canadian Consumers Asked To Participate in Pact
GENERAL MOTORS: Recalls Various Cars Because of Accident Hazard
GENERAL MOTORS: Recalls 500T Cars Due to Windshield Wiper Defect
GENERAL MOTORS: Recalls 126T Corvettes For Lock Systems Defect
GENERAL MOTORS: Recalls 433,632 Vehicles Due to Fuel Leak Hazard

HAMILTON BEACH: Recalls 20,160 Espresso Makers For Injury Hazard
HARLEY DAVIDSON: Recalls 4T Dyna Glides Due To Fuel Leak Hazard
PABST BREWING: Jos. Schlitz Retirees File Suit On Drug Benefits
UNITED STATES: New Overtime Rules To Take Effect Later This Year
US FOREST SERVICE: To Hire New Workers To Help Diversity Effort

                  New Securities Fraud Cases

aaiPHARMA INC.: Marc Henzel Lodges Securities Lawsuit in E.D. NC
ADDECCO SA: Marc Henzel Launches Securities Lawsuit in E.D. NY
ADOLOR CORPORATION: Charles Piven Lodges Securities Suit in PA
ADOLOR CORPORATION: Marc Henzel Lodges Securities Lawsuit in PA
ASCONI CORPORATION: Charles Piven Lodges Securities Suit in FL

CANADIAN SUPERIOR: Bernstein Liebhard Lodges NY Securities Suit
CANADIAN SUPERIOR: Marc Henzel Lodges Securities Suit in S.D. NY
EUNIVERSE INC.: Marc Henzel Commences Securities Suit in C.D. CA
MASTEC INC.: Schatz & Nobel Commences Securities Suit in S.D. FL
MOBILITY ELECTRONICS: Marc Henzel Lodges Securities Suit in AZ

NDCHEALTH CORPORATION: Schiffrin & Barroway Files PA Stock Suit
NDCHEALTH CORPORATION: Cauley Geller Files Securities Suit in PA
NOVASTAR FINANCIAL: Wechsler Harwood Files Stock Suit in W.D. MO
ODYSSEY HEALTHCARE: Cauley Geller Lodges Securities Suit in TX
ODYSSEY HEALTHCARE: Charles Piven Lodges Securities Suit in TX

VASO ACTIVE: Scott + Scott Launches Securities Fraud Suit in MA

                         *********


ALFRED TEO: SEC Files Securities Lawsuit Due To Insider Trading
---------------------------------------------------------------
The Securities and Exchange Commission filed securities fraud
charges against Alfred S. Teo, Sr., and ten of his relatives,
friends and colleagues who collectively received approximately  
$1.8 million in illicit profits from insider trading in the
securities of Musicland Stores Corporation and C-Cube
Microsystems, Inc.  

Mr. Teo, a major Musicland shareholder, learned about a proposed
tender offer for Musicland, and then purchased Musicland stock
on the basis of this information prior to the company's public
announcement of the acquisition on December 7, 2000.  Mr. Teo
also tipped eight other defendants with this information, who
then purchased Musicland stock prior to the Musicland
Announcement.  

Additionally, Mr. Teo and two other defendants filed false Forms
13D with the Commission that materially understated their
ownership of Musicland stock, so that he could continue to buy
Musicland stock, but avoid triggering Musicland's "poison pill."  
By making these secret purchases of Musicland stock, and then
subsequently selling these shares, Mr. Teo made approximately  
$22 million in illicit profits.  

Mr. Teo also engaged in insider trading in the securities of C-
Cube.  Mr. Teo, a director of Cirrus Logic, Inc., which had been
negotiating to take-over C-Cube, misappropriated material, non-
public information about C-Cube and then purchased C-Cube stock
shortly before C-Cube announced on March 26, 2001, that it had
agreed to be acquired by another company.  Mr. Teo also tipped
another defendant with this information, who then purchased C-
Cube stock prior to the C-Cube Announcement.

The complaint named the following as defendants:

     (1) Mr. Teo, age 57, is a resident of Kinnelon, New Jersey
         and Fisher Island, Florida.  He is the Chairman of
         several companies which produce industrial plastics.  
         Mr. Teo's companies are the largest producer of plastic
         bags in North America.  Mr. Teo has been a director and
         audit committee member of two public companies:  
         Navarre Corporation, from May 1, 1998, to present; and
         Cirrus, from July 21, 1998, to April 10, 2001;

     (2) Teren Seto Handelman, age 41, is a resident of
         Montclair, New Jersey.  She is Teo's sister-in-law and
         the sole trustee of the MAAA Trust.  MAAA Trust is a
         New Jersey trust that Mr. Teo established for the
         benefit of his four sons;

     (3) John D. Reier, age 44, is a resident of Montville, New
         Jersey.  He is the CFO of Alpha Industries Corp., a
         company Mr. Teo controlled;

     (4) Charles D. Fortune, age 56, is a resident of Norwalk,
         Connecticut.  He sold plastic resin to Mr. Teo's
         plastic manufacturing companies;

     (5) Jerrold J. Johnston, age 57, is a resident of Trumbull,
         Connecticut.  A salesman in the plastics industry, he
         has had business relationships with Mr. Fortune and Mr.
         Teo;

     (6) Mark J. Lauzon, age 43, is a resident of Flemington,  
         New Jersey.  He sold raw material plastic to Teo's
         Companies;

     (7) Philip Sacks, age 74, is a resident of Englewood, New
         Jersey and Fisher Island, Florida.  He and Teo reside
         in the same luxury apartment building in Fisher Island;

     (8) Mitchell L. Sacks, age 40, is a resident of Demarest,
         New Jersey.  Mitchell Sacks is Phil Sacks' son and
         worked in Teo's offices running a hedge fund in which
         Teo and Phil Sacks invested;

     (9) Richard A. Herron, age 61, is a resident of Fisher
         Island, Florida.  He and Mr. Teo docked their yachts
         next to one another at Fisher Island;

    (10) Lawrence L. Rosen, age 59, is a resident of Old Tappan,
         New Jersey and Fisher Island, Florida.  He was the
         founder and former CEO of N2K, a publicly traded
         company that owned music websites, and was later merged
         into another company that sells CDs over the Internet;

    (11) David M. Ross, age 56, is a resident of Manitowoc,
         Wisconsin.  His company manufactured Teo's 118-foot
         luxury yacht.

The complaint alleges that Mr. Teo engaged in insider trading in
securities of Musicland Stores Corporation and tipped other
defendants who also traded.  Mr. Teo also allegedly engaged in
insider trading in securities of C-Cube Microsystems, Inc., and
failed to file required reports and made false and misleading
disclosures in reports filed with the Commission concerning the
true extent of his ownership and control of Musicland stock.
     
On December 7, 2000, Musicland announced that it would be
acquired by another company through a tender offer.  The price
of Musicland stock rose more than 30% following the
announcement.  As the largest shareholder of Musicland, Teo had
learned of the acquisition through several confidential
communications with Musicland senior management during the fall
of 2000.  After learning of the tender offer, but before it was
publicly announced, Teo purchased 45,000 shares of Musicland
stock.  Teo sold those shares after the announcement and
realized a profit of approximately $185,275.  Teo also tipped
defendants Teren Seto, Reir, Fortune, Lauzon, Phil Sacks,
Herron, Rosen and Ross (and Fortune then tipped defendant
Johnston), all of whom purchased Musicland stock prior to the
announcement.  Collectively, Teo's tippees realized profits in
excess of $1.1 million.

On March 26, 2001, C-Cube announced that it would be acquired by
another company.  The price of C-Cube stock rose more than 40%.   
Teo learned before the announcement that C-Cube was discussing a
potential merger because he was a director of Cirrus Logic, Inc.
(Cirrus), one of the companies that was discussing acquiring C-
Cube, and Teo attended confidential Cirrus board meetings at
which a potential acquisition was discussed.   After learning of
a potential acquisition of C-Cube, but before it was announced,
Teo purchased 35,000 shares of C-Cube stock.  Mr. Teo sold these
shares after the announcement and realized a profit of
approximately $180,012.  Teo also tipped defendant Mitchell
Sacks, who also purchased C-Cube stock prior to the announcement
and realized profits of approximately $115,155.
     
Teo also engaged in securities fraud by failing to file required
reports and by making false and misleading disclosures in
reports filed with the Commission concerning the extent of his
ownership and control of Musicland stock.  For instance, Teo,
the MAAA Trust (a trust for Teo's children), and Teren Seto, as
the MAAA Trust's sole trustee, filed Schedules 13D that falsely
under-reported the number of shares of Musicland stock that Teo
owned and controlled.  Teo sought to conceal the true extent of
his ownership and control of Musicland stock in order to avoid
the risk of triggering Musicland's shareholder rights plan, or
"poison pill."  Teo thereby concealed his purchase of nearly 6
million shares of Musicland stock above the poison pill trigger.  
Teo thereafter sold those shares realizing a profit of
approximately $22 million.
     
The Commission charged violations of Sections 10(b), 13(d),
14(e) and 16(a) of the Securities Exchange Act of 1934 and Rules
10b-5, 12b-20, 13d-1, 13d-2, 14e-3, and 16a-3 thereunder.  The
Commission seeks the relief from the defendants:

     (i) permanent injunctions;  

    (ii) disgorgement of all illicit profits;

   (iii) civil penalties; and

    (iv) officer and director bars against Teo and Rosen.  

The Commission filed its complaint in the U.S. District Court
for the District of New Jersey.
     
The Commission also announced that it reached settlements with
Fortune, Johnston and Rosen.  Without admitting or denying the
allegations in the Commission's complaint, Fortune Johnston and
Rosen each consented to final judgments that permanently
enjoined them, ordered them to disgorge their illicit profits
plus prejudgment interest, and imposed a civil penalty equal to
the illicit profits they obtained.  Rosen also agreed to the
entry of an order barring him from serving as an officer or
director for five years.
     
The suit is styled "SEC v. Alfred S. Teo, Sr., et al., Civil
Action No. CV 04-1815 (WGB)."


ALIANT TELECOM: Discovery Commences in Canada Retirement Lawsuit
----------------------------------------------------------------
Discovery is proceeding in the class action filed against Aliant
Telecom, Inc. (formerly NBTel, Inc.) in the New Brunswick Court
of Queens Bench.

132 former employees who took early retirement under a 1998
early retirement incentive program filed the suit, seeking
unquantified general damages in the amount of the difference
between what they received upon retirement in 1998, and what
they would have received had they retired under a 1999 early
retirement incentive program.

Pleadings are closed, Affidavits of Documents have been prepared
and Discovery of the Plaintiffs is complete.  Discovery of the
defendant's witnesses has not been completed.


AMERICAN HONDA: Recalls 440T Civic, Insight Cars For Overheating
----------------------------------------------------------------
American Honda Motor Company, Inc. is cooperating with the
National Highway Traffic Safety Administration (NHTSA) by
recalling around 440,000 Honda Civic, year 2001-2002 models and
Honda Insight, year 2000-2002 models.

On certain passenger vehicles, the low-beam terminal on the head
light wire harness can overheat and could cause the low beams to
fail without warning.  An unexpected loss of low beams could
result in a crash.

Dealers will inspect the head light switch and coupler for signs
of heat damage.  If heat damage is present, the dealer will
replace the switch and coupler.  If no heat damage is present,
the dealer will replace the head light switch and one mating pin
in the coupler.  The manufacturer has reported that owner
notification was to begin on April 5, 2004.  Owners may contact
Honda at 1-800-999-1009.


ARMOR HOLDINGS: Denies Allegations in FL Bullet-Proof Vest Suit
---------------------------------------------------------------
Armor Holdings, Inc. (NYSE: AH) categorically rejected in a
statement the allegations in the complaint filed in Florida by a
group of class action attorneys on behalf of the National
Association of Police Organizations (NAPO) regarding Zylon-based
body armor.

"Although other manufacturers have experienced failures with
their body armor, to our knowledge, none of Armor Holdings' body
armor, with or without the Zylon fabric, has ever failed to
perform to its certified level in the field," the Company said
in a press release.

The Company also asserts that no governmental authority or
agency has claimed that any of its vests are defective in any
way.  "Contrary to the conclusions drawn by plaintiffs'
attorneys, even the National Institute of Justice (NIJ) has
stated that its preliminary test results are statistically
inconclusive and unreliable," the statement continued.

The Company also states that it constantly tests and evaluates
all of its products and the ballistic material of which they are
comprised to ensure that they perform at the levels for which
they are warranted.  The Company reiterated its confidence in
the integrity of its products and their ability to perform both
as certified by the NIJ and as warranted by the Company.

The suit continues "Armor Holdings believes that this
irresponsible lawsuit engenders fear in the law enforcement
community, discouraging proper use of body armor, and thereby
puts the lives of our police men and women in greater danger."

The Company said it will continue to support and cooperate with
the Department of Justice in its initiatives undertaken to
evaluate the performance of body armor and the development of
testing standards and protocols for aged vests.

For more details, visit the firm's Website:
http://www.armorholdings.com.  


ASHLEY FURNITURE: Recalls Bunk Beds Due to Strangulation Hazard
---------------------------------------------------------------
Ashley Furniture Industries, Inc. is cooperating with the U.S.
Consumer Product Safety Commission by voluntarily recalling
22,476 Ashley "Trails End," "Cottage Retreat," and "Stages"
bunk beds.  

There are gaps between parts of the bunk bed that violate
federal safety standards and can be entrapment or strangulation
hazards to children.  For model B383, the gap between the end
rails on the upper bunk is too large. For models B213 and B233,
the gap between the guardrails of the upper bunk can be widened
with pressure, presenting an entrapment hazard.  Federal
standards for bunk beds are designed to protect children against
entrapment and strangulation.  No injuries have been reported.

These bunk bed models are recalled for repairs: B383-58T,
B383-57T, B213-58, and B233-58.  The B383 models are sold under
the group name "Trails End."  The B213 is sold under the group
name "Cottage Retreat."  The B233 is sold under the group name
"Stages."  The model numbers are on product stickers on each
bunk bed.  On the B383 model, the product sticker is on the
inside of the lower rail on the top bunk end panel. On the B213
and B233 models, the product sticker is on the inside of the
lower panel on the bottom bunk.

The bunk beds being recalled for repair were sold at furniture
stores nationwide.  Model B383 was sold beginning in December
2000.  Model B213 was sold beginning in May 2003.  Model B233
was sold beginning in June 2003.  All sales of the recalled bunk
beds ended in February 2004.  Model B383-57T sold for around
$299, model B383-58T sold for around $699, and Models B213 and
B233 sold for around $599.

For more details, contact the Company by Phone: (800) 999-2936
between 7:00 a.m. and 6:00 p.m. (CT) Monday through Friday and
8:00 a.m. to 5:00 p.m. (CT) on Saturday, or visit the Website:
http://www.ashleyfurniture.com.


CALIFORNIA BANKS: Consumers File Fraud Suit V. BofA, Wells Fargo
----------------------------------------------------------------
A class action lawsuit has been lodged against Bank of America
for charging employees business payroll account holders fees to
cash their paychecks, affecting tens of thousands of employers
and employees throughout California.  A similar suit is being
filed today against Wells Fargo Bank.

The plaintiffs in the suits against Bank of America and Wells
Fargo are two California employers who believe the banks' fees
have placed them in violation of Section 212 of the California
Labor Code, which requires that paychecks 'be negotiable and
payable in cash, on demand, without discount.'  The plaintiffs
are acting on behalf of all other employers in the state, many
who have lower-paid workers living paycheck to paycheck.

"We are seeking injunctions to stop the banks from charging the
$5 per paycheck cashing fees and obtain a refund of all such
fees already paid by thousands of employees in California --
mostly lower-paid workers who don't hold personal checking
accounts and rely on their employers' banks to cash their
checks," Nick Roxborough, a partner of Los Angeles based
Roxborough, Pomerance & Nye LLP who filed the lawsuits, said in
a statement.  "The total collected to date is easily in the tens
of millions of dollars."

The Department of Industrial Relations, which is responsible for
enforcing the labor code, already concurred during recent State
Senate hearings that the fees violate the California Labor Code,
stating that it subjects employers to criminal prosecution and
substantial penalties under Labor Code 215 and 225. The State
Senate has been holding hearings regarding this issue and
legislation is now pending to further prohibit banks from
charging these types of fees.

The suit against Bank of America was filed by a Visalia, Tulare
County nonprofit called Karis House, which runs six homes for
troubled teens. A Bakersfield firm called Ability Answering-
Paging Service is the plaintiff in the Wells Fargo suit.

Mr. Roxborough is confident the courts will rule in favor of the
plaintiffs and the California employers they represent, as well
as provide restitution for the employees who have been affected
by the banks' charges.  "We have great confidence that the right
thing will be done for both consumers and the employer
community," he adds.

For more details, contact Linda O'Hanlon of Roxborough,
Pomerance and Nye LLP by Phone: 818-386-1916


CIGNA HEALTHCARE: Physician Suit Settlement Appeals Dropped
-----------------------------------------------------------
All appeals challenging an agreement between CIGNA HealthCare
and some 700,000 physicians have been dismissed by a federal
court of appeals, clearing the way for implementation of the
settlement.  The settlement resolves for CIGNA HealthCare the
issues raised in physician lawsuits challenging the claims
payment practices of the nation's largest managed care
companies.

Under the Court-approved settlement, CIGNA HealthCare is, among
other things, offering multiple alternatives for monetary
compensation to physicians who participated in the class action,
simplifying administrative requirements and procedures, and
instituting new business practices intended to make it easier
for doctors to work with the company in meeting the needs of
patients.

CIGNA HealthCare also is committing funds to a foundation
governed by representatives of state medical societies. The
foundation will consider funding for a range of health care
initiatives such as expansion of the database of health care
information available to patients and providers, broadening
consumer access to cost-effective health insurance benefits, and
enhancing quality patient care.

In addition, CIGNA HealthCare is establishing a Physician
Advisory Committee through which physicians can offer input to
CIGNA on ways to enhance the delivery of health care and
maintain a strong, cooperative relationship between patients,
physicians and the company.

For more details, visit the Company's Website:
http://www.cigna.com.


DAIMLERCHRYSLER CORPORATION: Recalls Cars For Seat-Belt Defect
--------------------------------------------------------------
DaimlerChrysler Corporation is cooperating with the National
Highway Traffic Safety Administration by recalling 3,200 Dodge
Caravan/GrandCaravans, model 2005 and Chrysler Town & Country
vehicles, model 2005.

On certain minivans equipped without the available " Stow `n Go"
seating option, the right front seat belt retractor assembly may
have been improperly assembled.  As a result, the seat belt may
not properly restrain the occupant in a crash, increasing the
risk of injury.

Dealers will inspect the retractor assemblies and any seat belt
assembly that does not have the stake will be replaced.  The
manufacturer has reported that owner notification began on
February 23, 2004.  Owners may contact DaimlerChrysler at
1-800-853-1403.


ELECTRO SCIENTIFIC: Reaches $9M Settlement For Securities Suits
---------------------------------------------------------------
Electro Scientific Industries, Inc. reached a settlement for the
securities class action and shareholder derivative lawsuits
filed against it, Dow Jones Newswires reports.  The settlement
will require a total payment of almost $9.3 million.

The suits were commenced after the Company announced on March
20, 2003 that it planned to restate financial results for the
first and second fiscal quarters, news that sent its share
prices downward.  The suits allege that the Company artificially
inflated its results and improperly accounted for sales.  In
addition, plaintiffs claimed management didn't have a good gauge
on the financial health of the company and issued false
statements to that effect.

Under the settlement, the Company agreed to pay $3.8 million of
the settlement amount, while its insurer will pick up $5.4
million of the tab.  An Electro Scientific representative wasn't
available to say whether the company admitted any wrongdoing as
part of the settlement, Dow Jones reports.


ELI LILLY: Zyprexa Consumer Litigation Moved To New York Court
--------------------------------------------------------------
The lawsuits filed against Eli Lilly and Co. over its Zyprexa
drug are headed to the United States District Court in the
Eastern District of New York after the judicial panel on
multidistrict litigation denied the Company's request to
consolidate a growing number of Zyprexa cases in Indiana last
week, the Indianapolis Star reports.

Zyprexa, a drug used to treat schizophrenia and manic
depression, allegedly causes serious side effects, including
severe diabetic conditions.  It has recently become a target of
trial attorneys representing patients who used the drug.

"Obviously we don't like going to the defendant's home state" to
try the Zyprexa cases, Mark Burton, a trial attorney for Hersh &
Hersh in San Francisco that's handling several cases against
Lilly told the Star.  "They have a lot of political influence
there."

About two dozen federal cases around the country, plus future
cases, will be consolidated for pretrial purposes under Judge
Jack B. Weinstein.  Judge Weinstein is a noted expert on complex
multi district litigation who has written a practice guide on
the subject.

Lilly spokeswoman Marni Lemons told the Star, "We are pleased"
consolidation of the cases was granted, although she said
Indianapolis would have been a more convenient spot for the
company to litigate the cases.  Ms. Lemons said about 20 Zyprexa
lawsuits have been filed against Lilly since the first was filed
15 months ago.

She added that Zyprexa, which came on the market 7 1/2 years ago
and has been used by 14 million people, is "a successful and
widely prescribed product" that "is getting people out of
institutions and off the streets."


ENTRAN II HOSE: Canadian Consumers Asked To Participate in Pact
---------------------------------------------------------------
Canadians with leaking and defective radiant heating systems
that use a particular rubber hose may be eligible to receive
payments from a newly proposed class action settlement.

The hose, Entran II, is orange rubber and stamped with the name
"Heatway" or "Heatway Systems."  The hose is used for floors or
driveways to carry warm water that provides warmth and melts
snow.  The majority of hoses were sold or installed between 1989
and 1995.

The lawsuit has been brought on the behalf of homeowners who
allege the Entran II product is defective and that the hose is
prone to leaking when used under normal conditions.  The
Settlement Fund, which is payable over five years, will be at
least $196 million but could grow as large as $236 million,
according to recent court documents.

Because the hose is often buried under floors, embedded in
concrete and hidden above ceilings, it can be difficult for
homeowners to determine if they have one.  Repairing these
systems can be extremely costly and time-consuming, so
homeowners who believe they may have an Entran II hose are urged
to look into the matter as they may be eligible to receive
compensation.

The defendant, Goodyear Tire & Rubber Company, has denied all
allegations and maintains the hose works as intended if properly
maintained and used as directed.

For more details, call 1-800-254-9222 or visit the Website:
http://www.entrainiisettlement.com.  


GENERAL MOTORS: Recalls Various Cars Because of Accident Hazard
---------------------------------------------------------------
General Motors Corporation is cooperating with the National
Highway Traffic Safety Administration by recalling 68,875 cars,
namely:

     (1) Cadillac Escalade/ESV/EXT, Years 2003-2004;

     (2) Chevrolet Avalanche, Years 2003-2004;

     (3) Chevrolet Express, Years 2003-2004;

     (4) Chevrolet Silverado, Years 2003-2004;

     (5) Chevrolet Suburban, Years 2003-2004;

     (6) Chevrolet Tahoe, Years 2003-2004;

     (7) GMC Savana, Years 2003-2004;

     (8) GMC Sierra, Years 2003-2004;

     (9) GMC Yukon/Yukon XL, Years 2003-2004;

    (10) Hummer H2, Years 2003-2004

Certain sport utility vehicles, pickup trucks, and passenger
vans fail to comply with the requirements of Federal Motor
Vehicle Safety Standard No. 135, "Passenger Car Brake Systems."
Some of these vehicles were produced with an out-of-
specification brake hydro-boost housing relief valve bore.
Consequently, the valve O-ring seal may fracture. Steering
efforts may be slightly increased while braking or parking.
Under certain driving conditions, a fractured seal may also
require an increase in the applied brake pedal effort to achieve
the same vehicle deceleration.

Dealers are to replace the hydro-boost relief valve. The
manufacturer has reported that owner notification is expected to
begin during the second quarter of 2004. Owners may contact
Cadillac at 1-866-982-2339; Chevrolet at 1-800-630-2438; GMC at
1-866-996-9463; or Hummer at 1-866-486-6376.


GENERAL MOTORS: Recalls 500T Cars Due to Windshield Wiper Defect
----------------------------------------------------------------
General Motors Corporation is cooperating with the National
Highway Traffic Safety Administration is recalling 581,394 cars,
namely:

     (1) Chevrolet TrailBlazer/TrailBlazer EXT, year 2002-2003;

     (2) GMC Envoy/ Envoy XL, Year 2002-2003;

     (3) Oldsmobile Bravada, Year 2002-2003;

The windshield wipers on these sport utility vehicles may fail
to turn on, unexpectedly stop working, fail to turn off/on by
themselves (moisture sensitive wiper system), or the washer pump
may operate continuously because water can enter the wiper
module and either cause a short circuit or corrosion of
components within the module. Driver visibility could be
reduced, which could result in a crash.

Dealers will cover the windshield wiper module vent hole with a
patch. Also, the wiper motor, circuit board, and electrical
connector will be inspected for signs of water intrusion and/or
corrosion and be replaced as required. The manufacturer has
reported that owner notification is expected to begin during the
third quarter of 2004. Owners may contact Chevrolet at 1-800-
630-2438; GMC at 1-866-996-9463; or Oldsmobile at 1-800-630-
6537.


GENERAL MOTORS: Recalls 126T Corvettes For Lock Systems Defect
--------------------------------------------------------------
General Motors Corporation is cooperating with the National
Highway Traffic Safety Administration by recalling 126,624
Chevrolet Corvette, year 1997-2004 models, manufactured from
September 1996 to January 2004.

On certain passenger vehicles equipped with electronic column
lock systems (ECL), when the ignition switch is turned to
"lock," the ECL prevents turning of the steering wheel. When the
vehicle is started, the ECL unlocks the steering column. The
vehicle is designed so that if the column fails to unlock when
the vehicle is started and the customer tries to drive away, the
fuel supply will be shut off stopping the engine. This prevents
the vehicle from being driven when it cannot be steered.
However, if voltage at the Powertrain Control Module is low or
interrupted, the fuel shut off may not occur and the vehicle can
be driven while the steering column is locked. If this occurs, a
crash could occur.

On vehicles equipped with an automatic transmission, the dealer
will disable the steering column lock by removing the column
lock plate. When the ignition key is removed, the transmission
shifter will lock, but the steering column will not lock. On
vehicles equipped with a manual transmission, the dealer will
reprogram the powertrain control module. The steering column on
these vehicles will continue to lock when the key is removed.
The manufacturer has reported that owner notification is
expected to begin during the second quarter of 2004. Owners may
contact Chevrolet at 1-800-630-2438.


GENERAL MOTORS: Recalls 433,632 Vehicles Due to Fuel Leak Hazard
----------------------------------------------------------------
General Motors Corporation is cooperating with the National
Highway Traffic Safety Administration by voluntarily recalling
433,632 cars, namely:

     (1) Buick LeSabre, year 1998-1999,

     (2) Oldsmobile 88, Year 1998-1999,

     (3) Pontiac Bonneville, Year 1998-1999


On certain passenger vehicles equipped with 3800 V6 (l36)
engines and certain Delphi fuel pressure regulators, the
regulators have a much higher than usual rate of fuel leaks. A
leak can allow fuel to enter the intake manifold through a
vacuum line. If the engine does not start when cranked, the fuel
from the leaking regulator and a mistimed spark can cause a
backfire. The backfire can rupture the intake manifold. The
rupture of the intake manifold can displace a fuel line, pulling
an injector out of place, and causing a fuel leak and possible
fire.

Dealers will install new fuel pressure regulators with improved
diaphragms. The manufacturer has reported that owner
notification is expected to begin during the second quarter of
2004. Owners may contact Buick at 1-866-608-8080; Oldsmobile at
1-800-630-6537; or Pontiac at 1-800-620-7668.


HAMILTON BEACH: Recalls 20,160 Espresso Makers For Injury Hazard
----------------------------------------------------------------
Hamilton Beach/Proctor-Silex, Inc. is cooperating with the
Consumer Product Safety Commission by voluntarily recalling
20,160 Hamilton Beach Cappuccino Plus Espresso and Cappuccino
Makers.  The steam tube inside the espresso/cappuccino maker can
burst under pressure, presenting a risk of injury to consumers.
This can occur if the frothing nozzle becomes clogged and the
espresso button is pushed while attempting to froth milk.  
Hamilton Beach has received 10 reports of burst steam tubes, one
of which included a minor burn.

The recalled units are Hamilton Beach(r) Cappuccino Plus(tm)
Espresso and Cappuccino Maker, model 40714.  They are black
plastic and stainless steel.  The Hamilton Beach(r) brand name
is printed on the front of the unit, and the model number is
printed on the bottom.

Internet retailers and discount department stores sold these
items nationwide from March 2003 through March 2004 for
approximately $70.

Hamilton Beach will ship free replacement espresso/cappuccino
makers to consumers.  For more details, contact the Company by
Phone: (800) 672-5872, Monday through Friday, 8 a.m. to 8 p.m.
(ET), or visit the firm's Website: http://www.hamiltonbeach.com


HARLEY DAVIDSON: Recalls 4T Dyna Glides Due To Fuel Leak Hazard
---------------------------------------------------------------
Harley-Davidson Motor Company is cooperating with the National
Highway Traffic Safety Administration by recalling 4,593 Harley
Davidson Dyna Glides, year 2004 model.  These were manufactured
from September to November 2003.

On certain fuel-injected motorcycles, the inner line of the fuel
hose could separate, causing a fuel leak. Fuel leakage, in the
presence of an ignition source, could result in a fire.

Dealers will replace the fuel line assembly. The manufacturer
has reported that owner notification began on February 12, 2004.
Owners may contact Harley-Davidson at 1-414-342-4680.


PABST BREWING: Jos. Schlitz Retirees File Suit On Drug Benefits
---------------------------------------------------------------
Pabst Brewing Co. (formerly known as Jos. Schlitz Brewing Co.)
faces a class action filed in the United States District Court
in Milwaukee, Wisconsin by a group of Jos. Schlitz retirees,
claiming that their prescription drug benefits have been
improperly curtailed, the Milwaukee Sentinel reports.

Jos. Schlitz closed its Milwaukee brewery in 1981 and sold it to
Stroh Brewery Co. in 1982.  Pabst, based in San Antonio, Texas,
bought Stroh in 1999.

The suit was filed by three Schlitz retirees and their wives:
Raymond and Nathalie Zielinski, of Cedarburg; Raymond and
Dorothy Held, of Oak Creek, and Robert and Viola Ballenger, of
Sun City, Arizona.  The suit charges Pabst of reducing
prescription drug benefits on January 1 by increasing co-
payments and enacting other changes.  The suit alleges that
those actions violated a promise made in 1981 to provide
lifetime health benefits to Schlitz retirees and their spouses.  
The suit was filed on behalf of 301 Schlitz retirees and their
spouses, and is claiming class action status.

Pabst President Brian Kovalchuk declined to comment Thursday,
saying the company had not yet seen the lawsuit, the Milwaukee
Sentinel reports.

Pabst's changes included co-payments of $5 to $125 for a 90-day
supply if the drugs are ordered through Walgreen's mail service.
The brewer also now requires retirees to pay all costs over a
maximum annual benefit of $3,000, the lawsuit said.  The suit
wants a judge to order Pabst to provide the prescription drug
benefits that were promised in 1981. It also wants Pabst to
compensate the retirees for their higher co-payments.


UNITED STATES: New Overtime Rules To Take Effect Later This Year
----------------------------------------------------------------
The United States Department of Labor's new overtime rules are
expected to take effect by late August this year, at the
earliest, the Journal News reports.  

The rules specify which workers are entitled to overtime pay and
extended overtime protection to classes of employees who were
excluded under an original proposal by the Bush administration
last year.  Among its key provisions are:

     (1) Workers earning $23,660 or less are guaranteed overtime
         beyond a 40-hour work week, regardless of what work
         they perform.  The threshold under the existing rules
         is $8,060;

     (2) A broad range of blue-collar and public-safety workers
         will qualify for overtime, including police and
         firefighters, paramedics, emergency medical
         technicians, licensed practical nurses and manual
         laborers who perform work involving repetitive
         operations with their hands;

     (3) Most employees who earn at least $100,000 a year will
         not qualify for overtime, a threshold that was
         increased from $65,000 under the Labor Department's
         original proposal last year.  Employees who earn at
         least $100,000 must "customarily and regularly" perform
         duties that disqualify them from overtime.

Labor Secretary Elaine Chao told the Journal News that that the
new rules are needed to update obsolete regulations that include
job titles such as key punch operator, straw boss and legman.  
The confusion over what types of employees are entitled to
overtime has created "a legal nightmare" and generated more
federal class-action lawsuits than complaints about
discrimination, she said.  "Our intent has always been to
strengthen overtime protection for workers," Ms. Chao said.

Many parties and labor unions are studying the new rules to
determine their impact.  Mario Cilento, spokesman for the New
York state AFL-CIO, told the Journal News the union was studying
yesterday's rules.  He remained skeptical that the Bush
administration was trying to improve benefits for workers.  
"They came in here with an agenda, and they're trying to carry
it through at the expense of millions of working men and women,"
he said.

Robert Heiferman, an attorney with Jackson Lewis in White
Plains, a law firm that chiefly represents employers in work-
force issues, said he doubted that many workers in the Hudson
Valley would lose overtime protections.  The definitions of
exempt employees are clearer under the new rules and would bar
companies from exempting workers on overtime by merely changing
titles, he said.

Even well-intentioned employers are confused by the existing
regulations, and legal publications and professional journals
have disagreed about which workers are covered and which aren't,
he added, the Journal News states.


US FOREST SERVICE: To Hire New Workers To Help Diversity Effort
---------------------------------------------------------------
The United States Forest Services is recruiting for 300 to 500
permanent part-time jobs, as part of the requirements of a 2002
settlement with Hispanic employees, who charged the agency with
discrimination in terms of hiring, the Associated Press reports.

The service is conducting job fairs in Sacramento, Fresno and
Arcadia, near Los Angeles, in an effort to diversify its
California firefighting ranks by recruiting job applicants from
areas with ethnic populations.

At present, 80 percent of the service's firefighters are white,
most hailing from communities near mountains or national
forests.  The service's permanent employees are 9.8% Hispanic,
compared with about 35 percent for the state's population.  

The available jobs pay $8 to $10 an hour, and includes work on
fire engines, hotshot crews, smokejumper crews, helicopter-based
hand crews, or regular hand crews.  Recruits who complete the
Sacramento training academy and 4,000-hour apprenticeship
program will have a job for 26 weeks each summer without
reapplying.  The service already has hired more than 1,200
seasonal, non-permanent firefighters for what it is expecting to
be another extreme fire season, AP reports.


                  New Securities Fraud Cases


aaiPHARMA INC.: Marc Henzel Lodges Securities Lawsuit in E.D. NC
----------------------------------------------------------------
The Law Offices of Marc S. Henzel initiated a securities class
action in the United States District Court for the Eastern
District of North Carolina, Southern Division, on behalf of
persons who purchased or otherwise acquired publicly traded
securities of aaiPharma Inc. (NASDAQ: AAII) between July 23,
2003 and February 4, 2004, inclusive.  The lawsuit was filed
against aaiPharma and Philip S. Tabbiner and William L. Ginna.


The complaint alleges that Defendants violated Sections 10(b)
and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5
promulgated thereunder.  Specifically, the complaint alleges
that, throughout the Class Period, Defendants issued numerous
statements to the market concerning the Company's financial
results, which failed to disclose and or misrepresented that the
Company's core business was deteriorating, that the company was
unloading inventory onto wholesalers in order to meet sales
projections, and that the aforementioned practice in order to
keep its stock price up in order to fend off a third party
suitor.

On February 5, 2004, aaiPharma announced that the Company
expected net revenues to be between $340 million and $355
million for 2004. Diluted earnings per share for 2004 were
expected to remain, as previously disclosed, between $1.45 and
$1.52. Earnings were expected in the range of $0.27 to $0.30 per
diluted share for the first quarter 2004. Additionally, the
Company announced that it was setting aside money to pay for
refunds on older medicines after an unusually high return rate
in the fourth quarter. In response to this news, shares of
aaiPharma fell 23%, or $6.36 per share to close at $21.24 per
share on very heavy volume.

For more details, contact Marc S. Henzel by Mail: 273 Montgomery
Ave., Suite 202, Bala Cynwyd, PA 19004 by Phone: 610-660-8000 or
888-643-6735 by Fax: 610-660-8080 or by E-Mail:
mhenzel182@aol.com   


ADDECCO SA: Marc Henzel Launches Securities Lawsuit in E.D. NY
--------------------------------------------------------------
The Law Offices of Marc S. Henzel initiated a securities class
action in the United States District Court for the Eastern
District of New York on behalf of purchasers of Adecco SA.
(NYSE: ADO) publicly traded securities during the period between
March 16, 2000 and January 9, 2004, inclusive.

The Complaint alleges that defendants violated Sections 10(b)
and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5
promulgated thereunder, by issuing a series of material
misrepresentations to the market between March 16, 2000 and
January 9, 2004, thereby artificially inflating the price of
Adecco common stock.

Specifically, the complaint alleges that, throughout the Class
Period, defendants issued numerous positive statements and filed
reports with the SEC which described the Company's increasing
financial performance. As alleged in the complaint, these
statements were materially false and misleading because they
failed to disclose and/or misrepresented the following adverse
facts, among others:

      (1) that the Company lacked adequate internal controls and
          was therefore unable to ascertain the true financial
          condition of the Company;

      (2) more specifically, that the Company's North American
          operations had material weaknesses in its internal
          controls; and

      (3) as a result, the values of the Company's net income
          and financial results were materially overstated at
          all relevant times.

On January 12, 2004, Adecco shocked the market when it announced
that it did not expect the audit of its consolidated financial
statements for the 2003 fiscal year, ended on December 28, 2003,
to be completed by Adecco's auditors, by the previously
announced release date of February 4, 2004.

The Company identified the following reasons for the delay:

     (i) the identification of material weaknesses in internal
         controls in the Company's North American operations of
         Adecco Staffing;

    (ii) the resolution of possible accounting, control and
         compliance issues in the Company's operations in
         certain countries; and

   (iii) the completion of the Company's efforts to address
         these matters and determine their effect on the
         Company's consolidated financial statements.

In response to this announcement, the prices of all Adecco
securities dropped sharply, with Adecco shares traded on the New
York Stock Exchange tumbling more than 30%, or $5.23 per share,
to close at $11.70 per share on extremely heavy volume.

For more details, contact Marc S. Henzel by Mail: 273 Montgomery
Ave., Suite 202, Bala Cynwyd, PA 19004 by Phone: 610-660-8000 or
888-643-6735 by Fax: 610-660-8080 or by E-Mail:
mhenzel182@aol.com   


ADOLOR CORPORATION: Charles Piven Lodges Securities Suit in PA
--------------------------------------------------------------
The Law Offices Of Charles J. Piven, P.A. initiated a securities
class action on behalf of shareholders who purchased, converted,
exchanged or otherwise acquired the common stock of Adolor Corp.
(Nasdaq:ADLR) between September 23, 2003 and January 14, 2004,
inclusive.

The case is pending in the United States District Court for the
Eastern District of Pennsylvania against defendant Adolor Corp.
and one or more of its officers and/or directors.  The action
charges that defendants violated federal securities laws by
issuing a series of materially false and misleading statements
to the market throughout the Class Period which statements had
the effect of artificially inflating the market price of the
Company's securities.

For more details, contact Charles J. Piven, P.A. by Mail: The
World Trade Center-Baltimore, 401 East Pratt Street, Suite 2525,
Baltimore, Maryland 21202, by Phone: 410-986-0036 or by E-mail:
hoffman@pivenlaw.com


ADOLOR CORPORATION: Marc Henzel Lodges Securities Lawsuit in PA
---------------------------------------------------------------
The Law Offices of Marc S. Henzel initiated a securities class
action in the United States District Court for the Eastern
District of Pennsylvania on behalf of purchasers of Adolor Corp.
(NASDAQ:ADLR) common stock during the period between September
23, 2003 and January 14, 2004.


The complaint charges Adolor and certain of its officers and
directors with violations of the Securities Exchange Act of
1934. Adolor is a development stage biopharmaceutical
corporation that discovers, develops and plans to commercialize
products to relieve pain while reducing the side effects of
currently marketed narcotics.

The complaint alleges that during the Class Period, defendants
disseminated materially false and misleading information
regarding Adolor's flagship product candidate Entereg(TM) and
the clinical trials for Entereg(TM) for the management of
postoperative ileus.  The true facts, which were known by each
of the defendants but concealed from the investing public during
the Class Period, were as follows:

     (1) the clinical trial failure in the Entereg(TM) Phase III
         302 study for postoperative ileus was directly related
         to objective failure of the therapy in certain patient   
         subgroups, particularly those patients treated for
         simple hysterectomy;

     (2) additional Entereg(TM) Phase III clinical trials
         composed of patient subgroups similar to the 302 study
         would risk repetition of the same therapy failures;

     (3) the 302 study failure at the 12 mg dosage was due to
         therapy failures in certain patient subgroups,
         particularly those patients treated for simple
         hysterectomy, and not "limited power" or insufficient
         numbers of patients in the study as defendants claimed;

     (4) despite representations to the contrary, defendants
         were in a position to make meaningful comparisons for
         the data and results between patient subgroups, for the
         302 and 313 studies, from the very beginning of the
         Class Period;

     (5) despite defendants' expressions of disbelief at
         suggestions by analysts that distinctly different
         results for certain patient subgroups had somehow
         impacted the quality of results for the 302 and 313
         clinical studies, defendants were fully aware of these
         differences and that the clinical program was indeed
         adversely impacted from the very beginning of the Class
         Period;

     (6) the Entereg(TM) Phase III 313 clinical study met the
         primary efficacy endpoint, at both dosage levels,
         because it excluded certain patient subgroups already
         known by defendants prior to the Class Period to
         produce disappointing results for the treatment of
         postoperative ileus;

     (7) the Entereg(TM) Phase III 308 prospective study was at
         great risk of failing to achieve statistically
         significant results for the primary efficacy endpoint,
         at both dosage levels, because it would include a large
         number of certain patient subgroups already known to
         produce disappointing results for the treatment of
         postoperative ileus;

     (8) elimination of certain patient subgroups already known
         to produce disappointing results for the treatment of
         postoperative ileus from the 313 study created an
         opportunity to present highly encouraging clinical
         results to the investment community at the very
         beginning of the Class Period, while deferring the
         prospect of disappointing results from the prospective
         308 study; and

     (9) since the Entereg(TM) Phase III pivotal studies were
         designed to study two different dosages across a number
         of patient subgroups in three separate trials,
         defendants were aware, from the very beginning of the
         Class Period, that the mixed results within the patient
         subgroups for the 302 and 313 studies confounded the
         results, making it difficult for the FDA to approve an
         Entereg(TM) NDA based on the prospect of disappointing
         results from the prospective 308 study.

As a result of the defendants' false statements, Adolor's stock
price traded at inflated prices during the Class Period, causing
millions of dollars of damages to the Class. On November 12,
2003, as shares traded at prices as high as $18.14, the company
sold 6,900,000 shares of its common stock for gross proceeds of
approximately $119 million.

On January 13, 2004, the company reported shocking news about
the third in the series of Phase III clinical trials for the
company's new drug application submission. On this news, the
price of Adolor's stock plunged 37%, trading as low as $13.73
per share, on an unprecedented volume of 12.7 million shares.

For more details, contact Marc S. Henzel by Mail: 273 Montgomery
Ave., Suite 202, Bala Cynwyd, PA 19004 by Phone: 610-660-8000 or
888-643-6735 by Fax: 610-660-8080 or by E-Mail:
mhenzel182@aol.com   


ASCONI CORPORATION: Charles Piven Lodges Securities Suit in FL
--------------------------------------------------------------
The Law Offices Of Charles J. Piven, P.A. initiated a securities
class action on behalf of shareholders who purchased, converted,
exchanged or otherwise acquired the common stock of Asconi
Corporation . (AMEX:ACD) between May 15, 2003 to March 23, 2004,
inclusive (the "Class Period").

The case is pending in the United States District Court for the
Middle District of Florida. The action charges that defendants
violated federal securities laws by issuing a series of
materially false and misleading statements to the market
throughout the Class Period which statements had the effect of
artificially inflating the market price of the Company's
securities.

For more details, contact Charles J. Piven, P.A. by Mail: The
World Trade Center-Baltimore, 401 East Pratt Street, Suite 2525,
Baltimore, Maryland 21202, by Phone: 410-986-0036 or by E-mail:
hoffman@pivenlaw.com


CANADIAN SUPERIOR: Bernstein Liebhard Lodges NY Securities Suit
---------------------------------------------------------------
Bernstein Liebhard & Lifshitz LLP initiated a securities class
action in the United States District Court for the Southern
District of New York on behalf of all persons who purchased or
acquired securities of Canadian Superior Energy, Inc. (AMEX:
SNG); (TSX: SNG) between November 17, 2003 through March 11,
2004, inclusive.

The Complaint charges Canadian Superior, Greg Noval, and Michael
Coolen with violations of Sections 10(b) and 20(a) of the
Securities Exchange Act of 1934, and Rule 10b-5 promulgated
thereunder.  More specifically, the Complaint alleges that
defendants issued a number of materially false and misleading
statements about its El Paso Mariner I-85 well offshore
operations in Nova Scotia, Canada.  These positive statements
failed to disclose and indicate:

     (1) that defendants knew or were reckless in not knowing
         that the "Mariner I-85 well" was virtually "dry";

     (2) that the actual costs of testing and drilling at the
         well were significantly exceeding the budgeted costs;

     (3) that a significant gas reservoir to support a
         commercial project did not exist;

     (4) that, as a result of the foregoing, the Company's
         positive announcements concerning the "Mariner I-85
         well" were lacking in a reasonable basis when made, and

     (5) that the defendants' positive statements only served to
         artificially inflate the value of its stock.

The Company shocked the market with its March 11, 2004
announcement that it had halted operations at the El Paso
Mariner I-85 well in the Atlantic Ocean off Nova Scotia,
following 3-1/2 months of drilling. On this news, shares of
Canadian Superior skidded 44.44%, or $1.44 per share, to close
at $1.80 per share on March 11, 2004 on unusual high volume.

For more details, contact the Shareholder Relations Department,
by Mail: Bernstein Liebhard & Lifshitz, LLP, 10 East 40th
Street, New York, New York 10016 by Phone: (800) 217-1522 or
(212) 779-1414 or by E-mail: SNG@bernlieb.com.   


CANADIAN SUPERIOR: Marc Henzel Lodges Securities Suit in S.D. NY
----------------------------------------------------------------
The Law Offices of Marc S. Henzel initiated a securities class
action in the United States District Court for the Southern
District of New York on behalf of purchasers of the securities
of Canadian Superior Energy Inc. (Amex: SNG) between November
17, 2003 and March 11, 2004, inclusive.

The complaint charges Canadian Superior, Greg Noval, and Michael
Coolen with violations of Sections 10(b) and 20(a) of the
Securities Exchange Act of 1934, and Rule 10b-5 promulgated
thereunder.  More specifically, the Complaint alleges that
defendants issued a number of materially false and misleading
statements about its El Paso Mariner I-85 well offshore
operations in Nova Scotia, Canada.  These positive statements
failed to disclose and indicate:

     (1) that defendants knew or were reckless in not knowing
         that the "Mariner \ I-85 well" was virtually "dry";

     (2) that the actual costs of testing and drilling at the
         well were significantly exceeding the budgeted costs;

     (3) that a significant gas reservoir to support a
         commercial project did not exist;

     (4) that, as a result of the foregoing, the Company's
         positive announcements concerning the "Mariner I-85
         well" were lacking in a reasonable basis when made, and

     (5) that the defendants' positive statements only served to
         artificially inflate the value of its stock.

The Company shocked the market with its March 11, 2004
announcement that it had halted operations at the El Paso
Mariner I-85 well in the Atlantic Ocean off Nova Scotia,
following 3-1/2 months of drilling. On this news, shares of
Canadian Superior skidded 44.44%, or $1.44 per share, to close
at $1.80 per share on March 11, 2004 on unusual high volume.

For more details, contact Marc S. Henzel by Mail: 273 Montgomery
Ave., Suite 202, Bala Cynwyd, PA 19004 by Phone: 610-660-8000 or
888-643-6735 by Fax: 610-660-8080 or by E-Mail:
mhenzel182@aol.com    


EUNIVERSE INC.: Marc Henzel Commences Securities Suit in C.D. CA
----------------------------------------------------------------
The Law Offices of Marc S. Henzel initiated a securities class
action in the United States District Court for the Central
District of California on behalf of purchasers of eUniverse Inc.
(Nasdaq: EUNI) common stock during the period between July 30,
2002 and May 5, 2003, inclusive.

The Complaint alleges that defendants violated Sections 10(b)
and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5
promulgated thereunder, by issuing a series of material
misrepresentations to the market between July 30, 2002 and May
5, 2003, thereby artificially inflating the price of eUniverse
common stock. Throughout the Class Period, as alleged in the
Complaint, defendants issued numerous statements and filed
quarterly reports with the SEC which described the Company's
increasing financial performance.

The Complaint alleges that these statements were materially
false and misleading because they failed to disclose and/or
misrepresented the following adverse facts, among others:

     (1) that the Company had materially overstated its net
         income and earnings per share;

     (2) that the Company lacked adequate internal controls and
         was therefore unable to ascertain the true financial
         condition of the Company; and

     (3) that as a result, the value of the Company's net income
         and financial results were materially overstated at all
         relevant times.

On May 6, 2003, before the opening of trading, the Company
shocked the market by announcing that it "intends to restate its
financial statements for the second and third quarters of the
year ended March 31, 2003" and possibly also for the first
quarter of fiscal 2003. The Company also told investors not to
rely on its reported financial results for the first three
quarters of fiscal 2003. The Company attributed the need for the
restatement to the "incorrect processing of certain transactions
within the Company's accounting system." The Company further
said that the restated financial results will differ materially
from the previously-reported results. Following this
announcement, the NASDAQ halted trading in eUniverse shares and
stated that the shares will remain halted until the company has
supplied additional information.

For more details, contact Marc S. Henzel by Mail: 273 Montgomery
Ave., Suite 202, Bala Cynwyd, PA 19004 by Phone: 610-660-8000 or
888-643-6735 by Fax: 610-660-8080 or by E-Mail:
mhenzel182@aol.com    


MASTEC INC.: Schatz & Nobel Commences Securities Suit in S.D. FL
----------------------------------------------------------------
Schatz & Nobel, P.C. initiated a securities class action in the
United States District Court for the Southern District of
Florida on behalf of all persons who purchased the publicly
traded securities of MasTec, Inc. (NYSE: MTZ) from May 13, 2003
through April 12, 2004 inclusive.

The Complaint alleges that MasTec, a telecommunications and
energy infrastructure company, and certain of its officers and
directors issued materially false statements.  Specifically,
defendants failed to disclose that the Company was prematurely
recognizing revenue on certain contracts, had overvalued
inventory, and had failed to take adequate reserves for bad
debt, cost overruns and projected losses on certain projects.  
As a result of the foregoing, MasTec's financial results were
materially inflated throughout the Class Period.

For more details, contact Schatz & Nobel toll-free at (800) 797-
5499, or by e-mail at sn06106@aol.com. To view a copy of the
lawsuit initiating the class action, or for more information
about class action cases and Schatz & Nobel, please visit the
website: http://www.snlaw.net.  


MOBILITY ELECTRONICS: Marc Henzel Lodges Securities Suit in AZ
--------------------------------------------------------------
The Law Offices of Marc S. Henzel initiated a securities class
action in the United States District Court for the District of
Arizona on behalf of purchasers of Mobility Electronics, Inc.
(Nasdaq: MOBE) publicly traded securities during the period
between September 2, 2003 and January 5, 2004, inclusive.

The complaint charges Mobility Electronics, Inc., Charles R.
Mollo and Joan W. Brubacher with violations of Sections 10(b)
and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5
promulgated thereunder. More specifically, the complaint alleges
that throughout the Class Period, defendants repeatedly
represented that it expected Mobility to earn $15 million in
revenues for the fourth quarter of 2003, which was attributable
in large part to the Company's agreement with Fellowes, Inc.
whereby Fellowes would globally market and distribute a line of
Fellowes- branded power products from Mobility, as well as
custom products based on Mobility's market-leading combination
AC/DC technology, through its vast worldwide distribution
network, encompassing nearly 30,000 retail stores (the "Fellowes
Agreement").

In truth and in fact, however, unbeknownst to investors, by the
start of the Class Period, Fellowes was not meeting its sales
forecasts and, accordingly, Mobility was not generating the
revenues and earnings it had anticipated from the Fellowes
Agreement. Prior to disclosing these adverse facts to the
investing public, Mobility completed a $15 million private
placement, purchased assets from InVision Software and InVision
Wireless using its artificially inflated stock as currency and
Mobility insiders unloaded more than $6 million of their
personally-held shares to the unsuspecting public.

Then, on January 5, 2004, Mobility shocked the market when it
announced that it expects revenue for the fourth quarter of 2003
to be approximately $1.0 million to $1.3 million less than the
Company's previous guidance of about $15 million.

For more details, contact Marc S. Henzel by Mail: 273 Montgomery
Ave., Suite 202, Bala Cynwyd, PA 19004 by Phone: 610-660-8000 or
888-643-6735 by Fax: 610-660-8080 or by E-Mail:
mhenzel182@aol.com    


NDCHEALTH CORPORATION: Schiffrin & Barroway Files PA Stock Suit
---------------------------------------------------------------
Schiffrin & Barroway, LLP initiated a securities class action in
the United States District Court for the Eastern District of
Pennsylvania on behalf of purchasers of the securities of
NDCHealth Corporation (NYSE: NDC) between October 1, 2003 and
March 31, 2004, inclusive, seeking to pursue remedies under the
Securities Exchange Act of 1934.

The complaint alleges that NDC, Walter M. Hoff, and Randolph L.
M. Hutto violated Sections 10(b) and 20(a) of the Securities
Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, by
issuing a series of material misrepresentations to the market
between October 1, 2003 and March 31, 2004, thereby artificially
inflating the price of NDC's common stock.

More specifically, the Complaint alleges that the Company failed
to disclose and misrepresented the following material adverse
facts known to defendants or recklessly disregarded by them:

     (1) that the Company was materially inflating its financial
         results by prematurely recognizing revenue in its
         physician business unit;

     (2) that the Company's practice of improperly recognizing
         revenue was in violation of Generally Accepted
         Accounting Principles ("GAAP"); and

     (3) that as a result, the Company's financial results were
         materially inflated at all relevant times.

On April 1, 2004, the Company issued a press release with the
headline: "NDCHealth Delays Fiscal Third Quarter Results."
Therein, the Company stated that it would delay release of its
2004 fiscal third quarter financial results and the conference
call previously scheduled for April 1 and April 2, 2004,
respectively. According to the Company, this decision was
prompted by the company's initiation of a review concerning
practices and procedures relating to the timing of revenue
recognition of sales to the value-added reseller channel in its
physician business unit.

News of this shocked the market. Shares of NDC's stock price
dropped nearly 20% to close at $22.70 on unusually large trading
volumes of nearly 4.8 million shares.

For more details, contact Marc A. Topaz, Esq. or Stuart L.
Berman, Esq. by Mail: Three Bala Plaza East, Suite 400, Bala
Cynwyd, PA 19004 by Phone: 1-888-299-7706 (toll free) or
1-610-667-7706 or by E-mail: info@sbclasslaw.com


NDCHEALTH CORPORATION: Cauley Geller Files Securities Suit in PA
----------------------------------------------------------------
Cauley Geller Bowman & Rudman, LLP initiated a securities class
action in the United States District Court for the Eastern
District of Pennsylvania on behalf of purchasers of NDCHealth
Corporation (NYSE: NDC) publicly traded securities during the
period between October 1, 2003 and March 31, 2004, inclusive.

The complaint alleges that NDC, Walter M. Hoff, and Randolph L.
M. Hutto violated Sections 10(b) and 20(a) of the Securities
Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, by
issuing a series of material misrepresentations to the market
between October 1, 2003 and March 31, 2004, thereby artificially
inflating the price of NDC's common stock.

More specifically, the Complaint alleges that the Company failed
to disclose and misrepresented the following material adverse
facts which were known to defendants or recklessly disregarded
by them:

     (1) that the Company was materially inflating its financial
         results by prematurely recognizing revenue in its
         physician business unit;

     (2) that the Company's practice of improperly recognizing
         revenue was in violation of Generally Accepted
         Accounting Principles (GAAP); and

     (3) that as a result, the Company's financial results were
         materially inflated at all relevant times.

On April 1, 2004, the Company issued a press release with the
headline: "NDCHealth Delays Fiscal Third Quarter Results."
Therein, the Company stated that it would delay release of its
2004 fiscal third quarter financial results and the conference
call previously scheduled for April 1 and April 2, 2004,
respectively.

According to the Company, this decision was prompted by the
company's initiation of a review concerning practices and
procedures relating to the timing of revenue recognition of
sales to the value-added reseller channel in its physician
business unit. News of this shocked the market. Shares of NDC's
stock price dropped nearly 20% to close at $22.70 on unusually
large trading volumes of nearly 4.8 million shares.

For more details, contact Samuel H. Rudman, Esq., David A.
Rosenfeld, Esq. or Jackie Addison by Mail: P.O. Box 25438,
Little Rock, AR 72221-5438 by Phone: 1-888-551-9944 by Fax:
1-501-312-8505 or by E-mail: info@cauleygeller.com


NOVASTAR FINANCIAL: Wechsler Harwood Files Stock Suit in W.D. MO
----------------------------------------------------------------
Wechsler Harwood LLP initiated a securities class action on
behalf of persons or entities who purchased or otherwise
acquired the securities of NovaStar Financial, Inc., (NYSE:NFI)
between October 29, 2003 and April 19, 2004, both dates
inclusive.

The action, entitled Tinega v. NovaStar Financial, Inc., et al.,
Case No. not yet assigned, is pending in the United States
District Court for the Western District of Missouri and names as
defendants, the Company and:

     (1) Scott F. Hartman, Chairman of the Board and Chief
         Executive Officer,

     (2) W. Lance Anderson, President, Chief Operating Officer
         and director, and

     (3) Rodney E. Schwatken, Vice President, Secretary,
         Treasurer, and Controller

The complaint charges defendants with violations of Sections
10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule
10b-5 promulgated thereunder.  More specifically, the Complaint
alleges that defendants failed to disclose and misrepresented
the following material adverse facts which were then known to
defendants or recklessly disregarded by them:

     (i) that the Company was operating branches in various
         states without obtaining the necessary regulatory
         licenses. Accordingly, a material amount of the
         Company's branch offices were conducting business in
         violation of the applicable laws and regulations;

    (ii) that the risk of the Company being subject to adverse
         regulatory action was heightened given the
         aforementioned facts. Accordingly, NovaStar's purported
         risk disclosures concerning regulatory oversight did
         not constitute meaningful cautionary language; and

   (iii) that the Company was materially overstating the growth
         of its network of branches as many of those purported
         branches either did not actually exist or were
         operating in violation of applicable law.

On April 12, 2004, an article appeared in The Wall Street
Journal entitled "Outside Audit: Novastar's Rise Has A Ring Of
Deja Vu." The article reported that in February 2004, Nevada
state authorities ordered Novastar to cease operations there
after a finding that none of the Company's branches were
licensed to do business in the state. Furthermore, according to
the article, "Nevada's top mortgage-lending regulator said he
found that most of the 15 branches that Novastar claimed to have
in the state didn't actually exist."

In response to the facts revealed in The Wall Street Journal
news article, the price of NovaStar common stock plummeted 31%
from $54.18 per share to $37.50 per share on extremely heavy
trading volume. Then, on April 19, 2004, the SEC announced that
it has begun an inquiry into NovaStar's business practices. On
news of the inquiry, Company shares took another beating,
dropping $7.21, or 18.5%, to close at $31.80. During the Class
Period, NovaStar stock had traded as high as $70.32 per share.

For more details, contact David Leifer by Mail: 488 Madison
Avenue, 8th Floor New York, New York 10022 by Phone:
(877) 935-7400 or by E-mail: dleifer@whesq.com


ODYSSEY HEALTHCARE: Cauley Geller Lodges Securities Suit in TX
--------------------------------------------------------------
Cauley Geller Bowman & Rudman, LLP initiated a securities class
action in the United States District Court for the Northern
District of Texas on behalf of purchasers of Odyssey Healthcare,
Inc. (Nasdaq: ODSY) publicly traded securities during the period
between May 5, 2003 and February 23, 2004, inclusive.

The complaint charges that Odyssey, Richard R. Burnham, David C.
Gasmire, and Douglas B. Cannon violated sections 10(b) and 20(a)
of the Exchange Act, and Rule 10b-5 promulgated thereunder, by
issuing a series of material misrepresentations to the market
between May 5, 2003 and February 23, 2004.

More specifically, the complaint alleges that defendants'
statements during the Class Period failed to disclose and
misrepresented the following material adverse facts which were
then known to defendants or recklessly disregarded by them:

     (1) that the Company's financial results were materially
         inflated because at least six of its Hospice programs
         exceeded the amounts they were entitled to receive in
         Medicare reimbursements;

     (2) that the Company admitted patients to its Hospice
         programs who were not eligible for Medicare yet claimed
         that such patients were;

     (3) the Company's financial results were a result of
         providing a level of care and services below the
         standards set forth under government guidelines because
         the Company's caseloads were heavier than industry
         norms;

     (4) that the Company could not keep up with its heady
         growth due to higher labor costs -- especially in
         California, which represented 13 percent to 15 percent
         of Odyssey's revenues;

     (5) that higher drug costs were hurting the Company's
         margins; and

     (6) that Odyssey was suffering from negative cash-flows.

On February 23, 2004, Odyssey announced that its first-quarter
profits would be below analysts' estimates. According to the
Company, it expected its 2004 earnings per share results to
reflect a 23 to 25 percent increase over 2003, or $1.03 to $1.05
for the year. For the first quarter of 2004, Odyssey expected
earnings per share of $0.20 to $0.22, (analysts' expected the
Company to earn earnings per share of $0.25) compared to $0.19
for the first quarter of 2003. News of this shocked the market
with shares of Odyssey falling $7.11 per share, or 26 percent,
to close at $20.32 per share on February 24, 2004.

In its April 12, 2004 edition, Barron's published an article
highlighting the Company's operational issues. Therein, Barron's
articulated that there are signs that the Company can't keep up
with its heady growth. "Higher labor costs -- especially in
California, which represents 13%-15% of its revenues -- as well
as higher drug costs hurt Odyssey's margins in last year's
fourth quarter. In reporting those results on Feb. 23, the
company forecast lower- than-expected earnings for this year.
Another red flag: Odyssey disclosed that, in its most recent
quarter, six of its programs exceeded the amounts they were
entitled to receive in Medicare reimbursements, raising
questions about whether patients admitted to its programs are
truly eligible."

Additionally, the article pointed out: "There are also
suggestions that some of Odyssey's strong growth is the result
of providing a level of care and services below the standards
set forth under government guidelines, including providing
adequate bereavement services for patients' families."

For more details, contact Samuel H. Rudman, Esq., David A.
Rosenfeld, Esq., Jackie Addison by Mail: P.O. Box 25438, Little
Rock, AR 72221-5438 by Phone: 1-888-551-9944 by Fax:
1-501-312-8505 or by E-mail: info@cauleygeller.com


ODYSSEY HEALTHCARE: Charles Piven Lodges Securities Suit in TX
--------------------------------------------------------------
Law Offices Of Charles J. Piven, P.A. today announced that a
securities class action was commenced on behalf of shareholders
who purchased, converted, exchanged or otherwise acquired the
common stock of Odyssey Healthcare, Inc. (Nasdaq:ODSY) between
May 5, 2003 and February 23, 2004, inclusive.  The case is
pending in the United States District Court for the Northern
District of Texas against the Company and one or more of its
officers and/or directors.

The action charges that defendants violated federal securities
laws by issuing a series of materially false and misleading
statements to the market throughout the Class Period which
statements had the effect of artificially inflating the market
price of the Company's securities.

For more details, contact Charles J. Piven, P.A. by Mail: The
World Trade Center-Baltimore, 401 East Pratt Street, Suite 2525,
Baltimore, Maryland 21202, by Phone: 410-986-0036 or by e-mail:
hoffman@pivenlaw.com


VASO ACTIVE: Scott + Scott Launches Securities Fraud Suit in MA
---------------------------------------------------------------
Scott + Scott, LLC initiated a securities class action in the
United States District Court for the District of Massachusetts
on behalf of purchasers of Vaso Active Pharmaceuticals, Inc.
(Nasdaq: VAPH) common stock during the period between December
11, 2003 and March 31, 2004.

On April 1, 2004 the SEC halted trading of Vaso Active; it has
since resumed trading and it opened today at ninety- five cents
per share.  The complaint charges Vaso Active and certain of its
officers and directors with violations of the U. S. securities
laws (Securities Exchange Act of 1934).  Vaso Active's principal
activity is to develop, manufacture and market pharmaceutical
products. The Company focuses on vaso active lipid encapsulated
and/or transdermal delivery technology drugs.

The complaint alleges that during the Class Period, defendants
issued false and misleading statements regarding Vaso Active's
key products. The true facts, which were known by each of the
defendants but actively concealed from the investing public
during the Class Period, were that the Company's claims that its
"clinical trial" for its deFEET product was "supervised by
independent physicians and analyzed by the New England Medical
Center in Boston" Massachusetts.

Further, it is alleged that this was grossly misleading in that
the New England Medical Center had nothing to do with the study
associated with the "clinical trial," that the New England
Medical Center was unable to draw any conclusions concerning the
effectiveness of the product and played no role in selecting the
patients and gathering evidence and that the trial was not
supervised by "independent physicians."

Next, the Company's so-called "clinical trial" was not new or
revolutionary but rather more than half a decade old, the
American Association of Medical Foot Specialists and its so-
called "endorsement" of the Company's deFEET product was of
little value, and contrary to defendants' claim that there was
significant demand for the Company's stock at an "institutional
level," there was little, if any, institutional demand for the
Company's shares.

On April 1, 2004, SEC regulators halted trading of Vaso Active
stock due to questions about the accuracy of assertions made in
the Company's press releases, annual report, registration
statement and public statements to investors regarding FDA
approval of certain of its products. The stock has resumed
trading, but far off from its value of over 7 dollars per share
on or about April 1, 2003.

For more details, contact Neil Rothstein by Mail: 108 Norwich
Avenue, Colchester, CT 06415 by Phone: 860/537-3818 by Fax:
860/537- 4432 or by E-mail: nrothstein@scott-scott.com.

                        *********


A list of Meetings, Conferences and Seminars appears in each
Wednesday's edition of the Class Action Reporter. Submissions
via e-mail to carconf@beard.com are encouraged.

Each Friday's edition of the CAR includes a section featuring
news on asbestos-related litigation and profiles of target
asbestos defendants that, according to independent researches,
collectively face billions of dollars in asbestos-related
liabilities.
                        *********


S U B S C R I P T I O N   I N F O R M A T I O N

Class Action Reporter is a daily newsletter, co-published by
Bankruptcy Creditors' Service, Inc., Fairless Hills,
Pennsylvania, USA, and Beard Group, Inc., Frederick, Maryland
USA.   Roberto Amor, Aurora Fatima Antonio and Lyndsey Resnick,
Editors.

Copyright 2004.  All rights reserved.  ISSN 1525-2272.

This material is copyrighted and any commercial use, resale or
publication in any form (including e-mail forwarding, electronic
re-mailing and photocopying) is strictly prohibited without
prior written permission of the publishers.

Information contained herein is obtained from sources believed
to be reliable, but is not guaranteed.

The CAR subscription rate is $575 for six months delivered via
e-mail.  Additional e-mail subscriptions for members of the same
firm for the term of the initial subscription or balance thereof
are $25 each.  For subscription information, contact Christopher
Beard at 240/629-3300.

                  * * *  End of Transmission  * * *